Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

CRISPR-enhanced engineering of therapy-sensitive cancer cells for self-targeting of primary and metastatic tumors.

Reinshagen C, Bhere D, Choi SH, Hutten S, Nesterenko I, Wakimoto H, Le Roux E, Rizvi A, Du W, Minicucci C, Shah K.

Sci Transl Med. 2018 Jul 11;10(449). pii: eaao3240. doi: 10.1126/scitranslmed.aao3240.

PMID:
29997250
2.

Adjustable Polyurethane Foam as Filling Material for a Novel Spondyloplasty: Biomechanics and Biocompatibility.

Jiang H, Sitoci-Ficici KH, Reinshagen C, Molcanyi M, Zivcak J, Hudak R, Laube T, Schnabelrauch M, Weisser J, Schäfer U, Pinzer T, Schackert G, Zhang X, Wähler M, Brautferger U, Rieger B.

World Neurosurg. 2018 Apr;112:e848-e858. doi: 10.1016/j.wneu.2018.01.174. Epub 2018 Feb 27.

PMID:
29410101
3.

Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas.

Choi SH, Stuckey DW, Pignatta S, Reinshagen C, Khalsa JK, Roozendaal N, Martinez-Quintanilla J, Tamura K, Keles E, Shah K.

Clin Cancer Res. 2017 Nov 15;23(22):7047-7058. doi: 10.1158/1078-0432.CCR-17-0077. Epub 2017 Sep 14.

PMID:
28912136
4.

Effects of Preoperative Simulation on Minimally Invasive Hybrid Lumbar Interbody Fusion.

Rieger B, Jiang H, Reinshagen C, Molcanyi M, Zivcak J, Grönemeyer D, Bosche B, Schackert G, Ruess D.

World Neurosurg. 2017 Oct;106:578-588. doi: 10.1016/j.wneu.2017.06.184. Epub 2017 Jul 10.

PMID:
28705704
5.

Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors.

Zhu Y, Bassoff N, Reinshagen C, Bhere D, Nowicki MO, Lawler SE, Roux J, Shah K.

Sci Rep. 2017 Jun 1;7(1):2602. doi: 10.1038/s41598-017-02483-9.

6.

Erratum to: First clinical results of minimally invasive vector lumbar interbody fusion (MIS-VLIF) in spondylodiscitis and concomitant osteoporosis: a technical note.

Rieger B, Jiang H, Ruess D, Reinshagen C, Molcanyi M, Zivcak J, Tong H, Schackert G.

Eur Spine J. 2017 Apr;26(4):1325. doi: 10.1007/s00586-017-4992-z. No abstract available.

PMID:
28213694
7.

First clinical results of minimally invasive vector lumbar interbody fusion (MIS-VLIF) in spondylodiscitis and concomitant osteoporosis: a technical note.

Rieger B, Jiang H, Ruess D, Reinshagen C, Molcanyi M, Zivcak J, Tong H, Schackert G.

Eur Spine J. 2017 Dec;26(12):3147-3155. doi: 10.1007/s00586-016-4928-z. Epub 2016 Dec 27. Erratum in: Eur Spine J. 2017 Feb 17;:.

PMID:
28028646
8.

Predictive modeling and in vivo assessment of cerebral blood flow in the management of complex cerebral aneurysms.

Walcott BP, Reinshagen C, Stapleton CJ, Choudhri O, Rayz V, Saloner D, Lawton MT.

J Cereb Blood Flow Metab. 2016 Jun;36(6):998-1003. doi: 10.1177/0271678X16641125. Epub 2016 Mar 23. Review.

9.

Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.

Redjal N, Reinshagen C, Le A, Walcott BP, McDonnell E, Dietrich J, Nahed BV.

J Neurooncol. 2016 May;127(3):505-14. doi: 10.1007/s11060-016-2054-8. Epub 2016 Feb 1.

PMID:
26830093
10.

Intracranial dural based chondroma.

Reinshagen C, Redjal N, Sajed DP, Nahed BV, Walcott BP.

J Clin Neurosci. 2016 Mar;25:161-3. doi: 10.1016/j.jocn.2015.05.052. Epub 2015 Oct 24.

PMID:
26602798
11.

Surgical Approaches to the Lumbar Hidden Zone: Current Strategies and Future Directions.

Reinshagen C, Redjal N, Molcanyi M, Rieger B.

EBioMedicine. 2015 Sep 8;2(9):1005-7. doi: 10.1016/j.ebiom.2015.09.010. eCollection 2015 Sep. No abstract available.

12.

A novel minimally invasive technique for lumbar decompression, realignment, and navigated interbody fusion.

Reinshagen C, Ruess D, Walcott BP, Molcanyi M, Goldbrunner R, Rieger B.

J Clin Neurosci. 2015 Sep;22(9):1484-90. doi: 10.1016/j.jocn.2015.03.019. Epub 2015 Jun 19.

PMID:
26100155
13.

A novel translaminar crossover approach for pathologies in the lumbar hidden zone.

Reinshagen C, Ruess D, Molcanyi M, Redjal N, Walcott BP, Goldbrunner R, Rieger B.

J Clin Neurosci. 2015 Jun;22(6):1030-5. doi: 10.1016/j.jocn.2015.01.013. Epub 2015 Apr 23.

PMID:
25913749
14.

Impurity of stem cell graft by murine embryonic fibroblasts - implications for cell-based therapy of the central nervous system.

Molcanyi M, Mehrjardi NZ, Schäfer U, Haj-Yasein NN, Brockmann M, Penner M, Riess P, Reinshagen C, Rieger B, Hannes T, Hescheler J, Bosche B.

Front Cell Neurosci. 2014 Sep 5;8:257. doi: 10.3389/fncel.2014.00257. eCollection 2014.

Supplemental Content

Loading ...
Support Center